Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

David Zusman’s New Fund Is Worth Tracking: Let’s See What It’s Up To

Talara Capital Management, a hedge fund founded by David Zusman, a former Perella Weinberg Partners portfolio manager, has been catching our attention recently, although it is still quite small and manages about $200 million in assets. This real asset investment partnership is focused on long-term (fundamental) investments on global resource and industrial companies.

Over the past few months, Mr. Zusman’s fund has been making some interesting moves worth tracking. By comparing its 13F filings for the period finished on June 30th and the one concluded on September 30th, we can form a basic idea of the way that Talara’s investments have changed and where they are being directed. Let’s take a look at some basic points:

Cutting down on oil.

Emerald Oil Inc (NYSEMKT:EOX) was the fund’s largest holding in terms of value by the end of the second quarter. Although the stock gained more than 50% in price since the beginning of the year, the third quarter was quite troubled, and this led the fund to sell 379,732 shares. However, it still owns 985,180 shares, valued at approximately $8.1 million.

Emerald Oil Inc (NYSEMKT:EOX)

Talara also sold out its participation -100,000 shares, worth almost $6 million- at Whiting Petroleum Corp (NYSE:WLL). However, the stock price escalated 10% since.

Looking at these, and other moves, like the Jones Energy Inc (NYSE:JONE) –its seventh largest holding by the end of Q2- sell out, one can notice that the fund is moving away from the oil & gas industry.

Where’s the money going?

Talara’s portfolio is turning toward techonology. Its current main holding is ATMI Inc (NASDAQ:ATMI), a tech materials provider with a market cap close to $1 billion. The fund added 209,687 shares to its portfolio during the third quarter. Since that moment, stock price has risen by more than 10%, and its holdings are now worth about $10.4 million.

The bullish sentiment here is most likely encouraged by the company’s position as a supplier for the top semiconductor manufacturers in the world. As semiconductor technologies advance, the firm is also prone to benefit from increased demand for materials, scale advantages and decreasing costs.

Bullish on basic materials.

The firm is also placing big bets–just like on the second quarter- on Ashland, a  specialty chemicals company in which Jana Partners has a big stake. Mr. Zusman’s holdings increased by 5,000 shares during the third quarter, to 99,873 shares, worth $6.6 million.

Rolling toward success.

Similar to the aforementioned case, is that of General Motors Company (NYSE:GM), of which the fund owns 191,241 shares, compared to 160,000 the previous quarter. Its holdings are currently valued at roughly $7.3 million. Finally, also making the fund’s top 5 picks is Harley-Davidson, Inc. (NYSE:HOG). Talara owns 110,000 shares (up from 95,000 on the previous quarter), valued at $7.2 million.

Disclosure: none

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.